Literature DB >> 22891307

Biophysical mechanisms of MRI signal frequency contrast in multiple sclerosis.

Dmitriy A Yablonskiy1, Jie Luo, Alexander L Sukstanskii, Aditi Iyer, Anne H Cross.   

Abstract

Phase images obtained with gradient echo MRI provide image contrast distinct from T1- and T2-weighted images. It is commonly assumed that the local contribution to MRI signal phase directly relates to local bulk tissue magnetic susceptibility. Here, we use Maxwell's equations and Monte Carlo simulations to provide theoretical background to the hypothesis that the local contribution to MRI signal phase does not depend on tissue bulk magnetic susceptibility but tissue magnetic architecture--distribution of magnetic susceptibility inclusions (lipids, proteins, iron, etc.) at the cellular and subcellular levels. Specifically, we show that the regular longitudinal structures forming cylindrical axons (myelin sheaths and neurofilaments) can be locally invisible in phase images. Contrary to an expectation that the phase contrast in multiple sclerosis lesions should always increase in degree along with worsening of lesion severity (which happens for all known MR magnitude-based contrast mechanisms), we show that phase contrast can actually disappear with extreme tissue destruction. We also show that the phase contrast in multiple sclerosis lesions could be altered without loss of nervous system tissue, which happens in mild injury to the myelin sheaths or axonal neurofilaments. Moreover, we predict that the sign of phase contrast in multiple sclerosis lesions indicates the predominant type of tissue injury-myelin damage (positive sign) vs. axonal neurofilament damage (negative sign). Therefore, our theoretical and experimental results shed light on understanding the relationship between gradient echo MRI signal phase and multiple sclerosis pathology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22891307      PMCID: PMC3435153          DOI: 10.1073/pnas.1206037109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Gradient echo plural contrast imaging--signal model and derived contrasts: T2*, T1, phase, SWI, T1f, FST2*and T2*-SWI.

Authors:  Jie Luo; Bharathi D Jagadeesan; Anne H Cross; Dmitriy A Yablonskiy
Journal:  Neuroimage       Date:  2012-01-28       Impact factor: 6.556

Review 2.  Imaging iron stores in the brain using magnetic resonance imaging.

Authors:  E Mark Haacke; Norman Y C Cheng; Michael J House; Qiang Liu; Jaladhar Neelavalli; Robert J Ogg; Asadullah Khan; Muhammad Ayaz; Wolff Kirsch; Andre Obenaus
Journal:  Magn Reson Imaging       Date:  2005-01       Impact factor: 2.546

Review 3.  Multiple sclerosis--the plaque and its pathogenesis.

Authors:  Elliot M Frohman; Michael K Racke; Cedric S Raine
Journal:  N Engl J Med       Date:  2006-03-02       Impact factor: 91.245

4.  Magnetic susceptibility-weighted MR phase imaging of the human brain.

Authors:  Alexander Rauscher; Jan Sedlacik; Markus Barth; Hans-Joachim Mentzel; Jürgen R Reichenbach
Journal:  AJNR Am J Neuroradiol       Date:  2005-04       Impact factor: 3.825

5.  Bulk magnetic susceptibility shifts in NMR studies of compartmentalized samples: use of paramagnetic reagents.

Authors:  S C Chu; Y Xu; J A Balschi; C S Springer
Journal:  Magn Reson Med       Date:  1990-02       Impact factor: 4.668

6.  Quantitation of intrinsic magnetic susceptibility-related effects in a tissue matrix. Phantom study.

Authors:  D A Yablonskiy
Journal:  Magn Reson Med       Date:  1998-03       Impact factor: 4.668

7.  Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime.

Authors:  D A Yablonskiy; E M Haacke
Journal:  Magn Reson Med       Date:  1994-12       Impact factor: 4.668

8.  Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.

Authors:  F D Lublin; S C Reingold
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

9.  Axonal transection in the lesions of multiple sclerosis.

Authors:  B D Trapp; J Peterson; R M Ransohoff; R Rudick; S Mörk; L Bö
Journal:  N Engl J Med       Date:  1998-01-29       Impact factor: 91.245

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  44 in total

1.  A torque balance measurement of anisotropy of the magnetic susceptibility in white matter.

Authors:  Peter van Gelderen; Hendrik Mandelkow; Jacco A de Zwart; Jeff H Duyn
Journal:  Magn Reson Med       Date:  2014-11-14       Impact factor: 4.668

Review 2.  Lorentzian effects in magnetic susceptibility mapping of anisotropic biological tissues.

Authors:  Dmitriy A Yablonskiy; Alexander L Sukstanskii
Journal:  J Magn Reson       Date:  2018-04-26       Impact factor: 2.229

3.  Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions.

Authors:  Martina Absinta; Pascal Sati; Matthew Schindler; Emily C Leibovitch; Joan Ohayon; Tianxia Wu; Alessandro Meani; Massimo Filippi; Steven Jacobson; Irene C M Cortese; Daniel S Reich
Journal:  J Clin Invest       Date:  2016-06-06       Impact factor: 14.808

4.  Sphere of Lorentz and demagnetization factors in white matter.

Authors:  Jeff H Duyn; Thomas M Barbara
Journal:  Magn Reson Med       Date:  2014-04-24       Impact factor: 4.668

Review 5.  Studying brain microstructure with magnetic susceptibility contrast at high-field.

Authors:  Jeff H Duyn
Journal:  Neuroimage       Date:  2017-02-24       Impact factor: 6.556

Review 6.  Contributions to magnetic susceptibility of brain tissue.

Authors:  Jeff H Duyn; John Schenck
Journal:  NMR Biomed       Date:  2016-05-30       Impact factor: 4.044

Review 7.  The role of iron in brain ageing and neurodegenerative disorders.

Authors:  Roberta J Ward; Fabio A Zucca; Jeff H Duyn; Robert R Crichton; Luigi Zecca
Journal:  Lancet Neurol       Date:  2014-10       Impact factor: 44.182

8.  Integrated Laplacian-based phase unwrapping and background phase removal for quantitative susceptibility mapping.

Authors:  Wei Li; Alexandru V Avram; Bing Wu; Xue Xiao; Chunlei Liu
Journal:  NMR Biomed       Date:  2013-12-11       Impact factor: 4.044

9.  On the role of neuronal magnetic susceptibility and structure symmetry on gradient echo MR signal formation.

Authors:  Alexander L Sukstanskii; Dmitriy A Yablonskiy
Journal:  Magn Reson Med       Date:  2013-02-04       Impact factor: 4.668

Review 10.  [Ultrahigh field MRI in context of neurological diseases].

Authors:  J Kuchling; T Sinnecker; I Bozin; J Dörr; V I Madai; J Sobesky; T Niendorf; F Paul; J Wuerfel
Journal:  Nervenarzt       Date:  2014-04       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.